{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:15:55Z","timestamp":1770959755061,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10822-013-9635-9","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T09:58:46Z","timestamp":1360576726000},"page":"161-171","source":"Crossref","is-referenced-by-count":17,"title":["2D- and 3D-QSAR studies of a series of benzopyranes and benzopyrano[3,4b][1,4]-oxazines as inhibitors of the multidrug transporter P-glycoprotein"],"prefix":"10.1007","volume":"27","author":[{"given":"Ishrat","family":"Jabeen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penpun","family":"Wetwitayaklung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard F.","family":"Ecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,12]]},"reference":[{"key":"9635_CR1","first-page":"3944","volume":"59","author":"C Wandel","year":"1999","unstructured":"Wandel C, Kim RB, Kajiji S, Guengerich P, Wilkinson GR, Wood AJ (1999) P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies. Cancer Res 59:3944\u20133948","journal-title":"Cancer Res"},{"key":"9635_CR2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.febslet.2005.12.060","volume":"580","author":"MM Gottesman","year":"2006","unstructured":"Gottesman MM, Ling V (2006) The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 580:998\u20131009","journal-title":"FEBS Lett"},{"key":"9635_CR3","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0959-8049(96)00047-0","volume":"32A","author":"JM Ford","year":"1996","unstructured":"Ford JM (1996) Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers. Eur J Cancer 32A:991\u20131001","journal-title":"Eur J Cancer"},{"key":"9635_CR4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1359-6446(03)03008-3","volume":"9","author":"S Ekins","year":"2004","unstructured":"Ekins S (2004) Predicting undesirable drug interactions with promiscuous proteins in silico. Drug Discov Today 9:276\u2013285","journal-title":"Drug Discov Today"},{"key":"9635_CR5","first-page":"243","volume-title":"Multidrug resistance: biological and pharmaceutical advances in antitumour","author":"GF Ecker","year":"2008","unstructured":"Ecker GF (2008) Inhibitors of P-glycoprotein-Hit identification and lead optimization. In: Colabufo NA (ed) Multidrug resistance: biological and pharmaceutical advances in antitumour, vol 37\/661 (2). Research Signpost, Kerala, pp 243\u2013259"},{"key":"9635_CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48\u201358","journal-title":"Nat Rev Cancer"},{"key":"9635_CR7","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1021\/jm980121y","volume":"41","author":"P Chiba","year":"1998","unstructured":"Chiba P, Holzer W, Landau M, Bechmann G, Lorenz K, Plagens B, Hitzler M, Richter E, Ecker G (1998) Substituted 4-acylpyrazoles and 4-acylpyrazolones: synthesis and multidrug resistance-modulating activity. J Med Chem 41:4001\u20134011","journal-title":"J Med Chem"},{"key":"9635_CR8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/1573406054864061","volume":"1","author":"D Kaiser","year":"2005","unstructured":"Kaiser D, Smiesko M, Kopp S, Chiba P, Ecker GF (2005) Interaction field based and hologram based QSAR analysis of propafenone-type modulators of multidrug resistance. Med Chem 1:431\u2013444","journal-title":"Med Chem"},{"key":"9635_CR9","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/jm201705f","volume":"55","author":"I Jabeen","year":"2012","unstructured":"Jabeen I, Pleban K, Rinner U, Chiba P, Ecker GF (2012) Structure\u2013activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein. J Med Chem 55:3261\u20133273","journal-title":"J Med Chem"},{"key":"9635_CR10","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1021\/jm980517+","volume":"42","author":"R Hiessbock","year":"1999","unstructured":"Hiessbock R, Wolf C, Richter E, Hitzler M, Chiba P, Kratzel M, Ecker G (1999) Synthesis and in vitro multidrug resistance modulating activity of a series of dihydrobenzopyrans and tetrahydroquinolines. J Med Chem 42:1921\u20131926","journal-title":"J Med Chem"},{"key":"9635_CR11","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1039\/C0CC03075A","volume":"47","author":"I Jabeen","year":"2011","unstructured":"Jabeen I, Wetwitayaklung P, Klepsch F, Parveen Z, Chiba P, Ecker GF (2011) Probing the stereoselectivity of P-glycoprotein-synthesis, biological activity and ligand docking studies of a set of enantiopure benzopyrano[3,4-b][1,4]oxazines. Chem Commun (Camb) 47:2586\u20132588","journal-title":"Chem Commun (Camb)"},{"key":"9635_CR12","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1021\/jm000941m","volume":"43","author":"M Pastor","year":"2000","unstructured":"Pastor M, Cruciani G, McLay I, Pickett S, Clementi S (2000) GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. J Med Chem 43:3233\u20133243","journal-title":"J Med Chem"},{"key":"9635_CR13","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1021\/jm0498349","volume":"47","author":"E Carosati","year":"2004","unstructured":"Carosati E, Sciabola S, Cruciani G (2004) Hydrogen bonding interactions of covalently bonded fluorine atoms: from crystallographic data to a new angular function in the GRID force field. J Med Chem 47:5114\u20135125","journal-title":"J Med Chem"},{"key":"9635_CR14","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1021\/jm049113+","volume":"48","author":"F Fontaine","year":"2005","unstructured":"Fontaine F, Pastor M, Zamora I, Sanz F (2005) Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors. J Med Chem 48:2687\u20132694","journal-title":"J Med Chem"},{"key":"9635_CR15","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.biochi.2010.06.015","volume":"92","author":"G Tedeschi","year":"2010","unstructured":"Tedeschi G, Nonnis S, Strumbo B, Cruciani G, Carosati E, Negri A (2010) On the catalytic role of the active site residue E121 of E. coli l-aspartate oxidase. Biochimie 92:1335\u20131342","journal-title":"Biochimie"},{"key":"9635_CR16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1021\/ci9003317","volume":"50","author":"S Sciabola","year":"2010","unstructured":"Sciabola S, Stanton RV, Mills JE, Flocco MM, Baroni M, Cruciani G, Perruccio F, Mason JS (2010) High-throughput virtual screening of proteins using GRID molecular interaction fields. J Chem Inf Model 50:155\u2013169","journal-title":"J Chem Inf Model"},{"issue":"Suppl 2","key":"9635_CR17","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0928-0987(00)00162-7","volume":"11","author":"G Cruciani","year":"2000","unstructured":"Cruciani G, Pastor M, Guba W (2000) VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. Eur J Pharm Sci 11(Suppl 2):S29\u2013S39","journal-title":"Eur J Pharm Sci"},{"key":"9635_CR18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/ci100423z","volume":"51","author":"C Obiol-Pardo","year":"2011","unstructured":"Obiol-Pardo C, Gomis-Tena J, Sanz F, Saiz J, Pastor M (2011) A multiscale simulation system for the prediction of drug-induced cardiotoxicity. J Chem Inf Model 51:483\u2013492","journal-title":"J Chem Inf Model"},{"key":"9635_CR19","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1021\/jm050529c","volume":"48","author":"G Cruciani","year":"2005","unstructured":"Cruciani G, Carosati E, De Boeck B, Ethirajulu K, Mackie C, Howe T, Vianello R (2005) MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. J Med Chem 48:6970\u20136979","journal-title":"J Med Chem"},{"key":"9635_CR20","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1016\/S0040-4039(00)78231-1","volume":"35","author":"JD Godfrey","year":"1994","unstructured":"Godfrey JD, Mueller RH, Sedergran TC, Soundararajan N, Colandrea VJ (1994) Improved synthesis of aryl 1,1-dimethylpropargyl ethers. Tetrahedron Lett 35:6405\u20136408","journal-title":"Tetrahedron Lett"},{"key":"9635_CR21","volume-title":"Probability and statistical inference","author":"RV Hogg","year":"1993","unstructured":"Hogg RV, Tanis EA (1993) Probability and statistical inference. Macmillan Publishing, New York"},{"key":"9635_CR22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0898-5529(90)90156-3","volume":"3","author":"J Gasteiger","year":"1990","unstructured":"Gasteiger J, Rudolph C, Sadowski J (1990) Automatic generation of 3D-atomic coordinates for organic molecules. Tetrahedron Comput Methodol 3:537\u2013547","journal-title":"Tetrahedron Comput Methodol"},{"key":"9635_CR23","unstructured":"Dur\u00e1n \u00c1, Pastor M (2011) An advanced tool for computing and handling GRid-INdependent. Descriptors. User Manual Version 1.06"},{"key":"9635_CR24","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1021\/ci800037t","volume":"48","author":"A Duran","year":"2008","unstructured":"Duran A, Martinez GC, Pastor M (2008) Development and validation of AMANDA, a new algorithm for selecting highly relevant regions in Molecular Interaction Fields. J Chem Inf Model 48:1813\u20131823","journal-title":"J Chem Inf Model"},{"key":"9635_CR25","doi-asserted-by":"crossref","unstructured":"Clementi M, Clementi S, Cruciani G, Pastor M (2000) Chemometric detection of binding sites of 7TM receptors. In: Bultinck P, Winter HD, Langenaeker W, Tollenaere JP (eds) Molecular modelling and prediction of bioreactivity. Kluwer Academic\/Plenum Publishers, New York, pp 207\u2013212","DOI":"10.1007\/978-1-4615-4141-7_24"},{"key":"9635_CR26","first-page":"1122","volume":"49","author":"P Chiba","year":"1996","unstructured":"Chiba P, Ecker G, Schmid D, Drach J, Tell B, Goldenberg S, Gekeler V (1996) Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance. Mol Pharmacol 49:1122\u20131130","journal-title":"Mol Pharmacol"},{"key":"9635_CR27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrd3187","volume":"9","author":"K Sugano","year":"2010","unstructured":"Sugano K, Kansy M, Artursson P, Avdeef A, Bendels S, Di L, Ecker GF, Faller B, Fischer H, Gerebtzoff G, Lennernaes H, Senner F (2010) Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov 9:597\u2013614","journal-title":"Nat Rev Drug Discov"},{"key":"9635_CR28","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","volume":"17","author":"TA Halgren","year":"1996","unstructured":"Halgren TA (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem 17:490\u2013519","journal-title":"J Comput Chem"},{"key":"9635_CR29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ardp.200300862","volume":"337","author":"K Pleban","year":"2004","unstructured":"Pleban K, Hoffer C, Kopp S, Peer M, Chiba P, Ecker GF (2004) Intramolecular distribution of hydrophobicity influences pharmacological activity of propafenone-type MDR modulators. Arch Pharm (Weinheim) 337:328\u2013334","journal-title":"Arch Pharm (Weinheim)"},{"key":"9635_CR30","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1021\/jm970786k","volume":"41","author":"I Pajeva","year":"1998","unstructured":"Pajeva I, Wiese M (1998) Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: a comparative molecular field analysis study. J Med Chem 41:1815\u20131826","journal-title":"J Med Chem"},{"key":"9635_CR31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/(SICI)1521-3838(199808)17:04<301::AID-QSAR301>3.0.CO;2-J","volume":"17","author":"IK Pajeva","year":"1998","unstructured":"Pajeva IK, Wiese M (1998) A comparative molecular field analysis of propafenone-type modulators of cancer multidrug resistance. Quant Struct\u2013Act Relat 17:301\u2013312","journal-title":"Quant Struct\u2013Act Relat"},{"key":"9635_CR32","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","volume":"323","author":"SG Aller","year":"2009","unstructured":"Aller SG, Yu J, Ward A, Weng Y, Chittaboina S, Zhuo R, Harrell PM, Trinh YT, Zhang Q, Urbatsch IL, Chang G (2009) Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323:1718\u20131722","journal-title":"Science"},{"key":"9635_CR33","first-page":"791","volume":"56","author":"G Ecker","year":"1999","unstructured":"Ecker G, Huber M, Schmid D, Chiba P (1999) The importance of a nitrogen atom in modulators of multidrug resistance. Mol Pharmacol 56:791\u2013796","journal-title":"Mol Pharmacol"},{"key":"9635_CR34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/qsar.19930120103","volume":"12","author":"M Baroni","year":"1993","unstructured":"Baroni M, Costantino G, Cruciani G, Riganelli D, Valigi R, Clementi S (1993) Generating optimal linear PLS estimations (GOLPE): an advanced chemometric tool for handling 3D-QSAR problems. Quant Struct\u2013Act Relat 12:9\u201320","journal-title":"Quant Struct\u2013Act Relat"},{"key":"9635_CR35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/qsar.19970160502","volume":"16","author":"P Chiba","year":"1997","unstructured":"Chiba P, Hitzler M, Richter E, Huber M, Tmej C, Giovagnoni E, Ecker G (1997) Studies on propafenone-type modulators of multidrug resistance III: variations on the nitrogen. Quant Struct\u2013Act Relat 16:361\u2013366","journal-title":"Quant Struct\u2013Act Relat"},{"key":"9635_CR36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ardp.200300817","volume":"337","author":"T Langer","year":"2004","unstructured":"Langer T, Eder M, Hoffmann RD, Chiba P, Ecker GF (2004) Lead identification for modulators of multidrug resistance based on in silico screening with a pharmacophoric feature model. Arch Pharm (Weinheim) 337:317\u2013327","journal-title":"Arch Pharm (Weinheim)"},{"key":"9635_CR37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.1432-1327.1998.2510252.x","volume":"251","author":"A Seelig","year":"1998","unstructured":"Seelig A (1998) A general pattern for substrate recognition by P-glycoprotein. Eur J Biochem 251:252\u2013261","journal-title":"Eur J Biochem"},{"key":"9635_CR38","first-page":"50","volume":"36","author":"A Seelig","year":"1998","unstructured":"Seelig A (1998) How does P-glycoprotein recognize its substrates? Int J Clin Pharmacol Ther 36:50\u201354","journal-title":"Int J Clin Pharmacol Ther"},{"key":"9635_CR39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/mp050071a","volume":"3","author":"P Crivori","year":"2006","unstructured":"Crivori P, Reinach B, Pezzetta D, Poggesi I (2006) Computational models for identifying potential P-glycoprotein substrates and inhibitors. Mol Pharm 3:33\u201344","journal-title":"Mol Pharm"},{"key":"9635_CR40","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1021\/jm0491851","volume":"48","author":"G Cianchetta","year":"2005","unstructured":"Cianchetta G, Singleton RW, Zhang M, Wildgoose M, Giesing D, Fravolini A, Cruciani G, Vaz RJ (2005) A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR. J Med Chem 48:2927\u20132935","journal-title":"J Med Chem"},{"key":"9635_CR41","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1021\/jm101421d","volume":"54","author":"F Broccatelli","year":"2011","unstructured":"Broccatelli F, Carosati E, Neri A, Frosini M, Goracci L, Oprea TI, Cruciani G (2011) A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields. J Med Chem 54:1740\u20131751","journal-title":"J Med Chem"},{"key":"9635_CR42","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejps.2008.09.009","volume":"36","author":"J Boccard","year":"2009","unstructured":"Boccard J, Bajot F, Di Pietro A, Rudaz S, Boumendjel A, Nicolle E, Carrupt PA (2009) A 3D linear solvation energy model to quantify the affinity of flavonoid derivatives toward P-glycoprotein. Eur J Pharm Sci 36:254\u2013264","journal-title":"Eur J Pharm Sci"},{"key":"9635_CR43","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1248\/cpb.50.854","volume":"50","author":"A Boumendjel","year":"2002","unstructured":"Boumendjel A, Beney C, Deka N, Mariotte AM, Lawson MA, Trompier D, Baubichon-Cortay H, Di Pietro A (2002) 4-Hydroxy-6-methoxyaurones with high-affinity binding to cytosolic domain of P-glycoprotein. Chem Pharm Bull (Tokyo) 50:854\u2013856","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"9635_CR44","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/med.10015","volume":"22","author":"A Boumendjel","year":"2002","unstructured":"Boumendjel A, Di Pietro A, Dumontet C, Barron D (2002) Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance. Med Res Rev 22:512\u2013529","journal-title":"Med Res Rev"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-013-9635-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-013-9635-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-013-9635-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T18:53:35Z","timestamp":1553626415000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-013-9635-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["9635"],"URL":"https:\/\/doi.org\/10.1007\/s10822-013-9635-9","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}